Abstract
A new sensitiser (4) for use in photodynamic therapy (PDT) has been developed to enable control of ROS production as a function of pH. This pH dependent PDT behaviour was tested in HeLa cells and in SCID mice bearing human xenograft pancreatic cancer (BxPC-3) tumours.
Original language | English |
---|---|
Pages (from-to) | 16832-16835 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 51 |
Issue number | 94 |
DOIs | |
Publication status | Published - 30 Sep 2015 |
Externally published | Yes |